The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.
Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.
The funds will support efforts to develop novel data compression strategies for handling various kinds of genomic data.
In addition to a significant increase in NIH's annual funding, the legislation would provide $10 billion over five years for an NIH Innovation Fund.
The recipients of the funding will develop tools to identify certain pathogens often implicated in infections in healthcare settings.
UC Davis' Simeon Boyd and his colleagues will continue genetic research into the condition to identify biomarkers, which could be used for early detection and treatment.
The database will be used to research new technologies and treatments, as well as to track the health outcomes of children with rare genetic disorders.
The award from the NIH will go toward development of a test for detecting common bacteria from blood with an initial focus on carbepenem-resistant Enterobacteriaceae.
The database has received a total of $35 million in funding, and in 2014 more than 180,000 scientists accessed it for their research.
The company will use the two-year grant to develop an automated, high-throughput, high-pressure system to better control DNA fragmentation.
The former commissioner of the FDA has returned to the venture capital firm New Enterprise Associates as a special partner on the healthcare investment team.
Astronauts have edited yeast genes on the International Space Station in an experiment designed to show how cells repair themselves in space.
Emory University has found that two of its researchers failed to divulge they had received funds from China, according to the Atlanta Journal-Constitution.
In Science this week: influence of the nuclear genome on human mitochondrial DNA, and more.